Merchants Bancorp (MBIN), the Carmel, Indiana-based regional bank with a sharp focus on multifamily housing finance and warehouse lending, has scripted one of the more compelling growth stories in community banking over the past decade. From humble roots with just $101 million in revenue in 2016, the company scaled to a whopping $1.45 billion by 2024—a staggering 1,333% increase, or roughly 38% compound annual growth rate (CAGR). This isn’t just numbers on a spreadsheet; it’s a narrative of opportunistic expansion fueled by low-rate environments, pandemic-era lending booms like PPP loans in 2020 (when revenue tripled to $410 million), and savvy navigation of the 2023 regional banking turmoil that felled SVB and others. MBIN’s leadership, led by Chairman, CEO, and major shareholder Michael R. Marhenke, leaned into niche markets where others feared to tread, building a loan book that propelled earnings per share (EPS) from $0.72 in 2016 to $6.32 in 2024. Yet, as we peel back the layers, recent insider moves and analyst forecasts paint a picture of maturing growth, cyclical pressures, and cautious optimism.
A Decade of Revenue Rocket Fuel
The revenue trajectory tells a tale of relentless execution. Starting with 157 employees in 2016 generating about $646,000 per head, MBIN ballooned headcount to 663 by 2024 while boosting revenue per employee to $2.19 million—a 239% jump that underscores operational leverage. This efficiency shines in metrics like revenue per share, which rocketed from $3.20 in 2016 to $32.34 in 2024 (910% growth), mirroring share count stability around 43-45 million diluted shares. Stock price action closely tracked this: lows climbed from $10.85 in 2017 to $35.56 in 2024 (227% rise), while highs hit $53.27 last year, rewarding early investors with multibagger returns.
Key driver? Multifamily and commercial real estate lending, which exploded post-2016 deregulation under Dodd-Frank tweaks and accommodative Fed policy. The 2020 COVID pivot—revenue up 58% to $410 million amid stimulus—juiced net income to $181 million (11x from 2019’s $77 million, or 1,334% surge), lifting EPS to $3.85. But correlation with macro events is stark: gross margins peaked at 92.8% in 2021 on high-margin lending but eroded to 46.2% by 2024 as rates rose and competition intensified. ROE, a critical gauge of shareholder value creation, held resilient at 20-30% through most years (peaking at 32% in 2020), far outpacing peers’ teens, thanks to disciplined capital allocation.
Profitability Peaks and Cyclical Clouds
Earnings before tax (EBT) followed suit, hitting $423 million in 2024 (673% from 2016’s $55 million), but margins tell a cautionary subplot. EBT margin slid from 54% mid-decade highs to 29.1% recently—a 46% relative drop—as funding costs rose post-2022 Fed hikes. Net income mirrored this, cresting at $320 million in 2024 before analysts pencil in a sharp 2025 pullback to $162 million (-50%, or $158 million decline). Why important? Net income funds dividends (MBIN yields ~2-3% historically) and buybacks, and this dip correlates with projected revenue halving to $667 million in 2025 from 2024’s $1.45 billion, likely tied to normalizing warehouse lending volumes after a 2023-24 peak.
Cash flows add texture: Free cash flow per share swung wildly, from negative teens (e.g., -$29.52 in 2019 on growth capex) to a stellar $22.40 in 2022, then back to -$19.03 in 2024 amid working capital swings ($2.77 billion positive, up from -$110 million prior). Capex stayed modest at -$0.41/share, signaling efficient scaling without empire-building bloat. ROA (1-2%) and ROIC (peaking 17% in 2018) confirm asset-light profitability, vital for banks where returns hinge on loan quality over fixed assets.
Balance Sheet: Fortress or Leverage Play?
MBIN’s sheet beefed up alongside growth. Shareholders’ equity surged from $206 million in 2016 to $2.24 billion in 2024 (987% gain, 27% CAGR), driving book value per share from $6.51 to $50.01 (668% rise). Total debt ballooned to $4.39 billion in 2024 (from $112 million, 3,818% increase), flipping net debt positive at $3.91 billion—important for liquidity risk in a high-rate world, especially post-2023’s unrealized loss scares at peers. Yet PB ratios stayed cheap (1.0-1.7x), and leverage funded the lending engine without eroding ROE below 20%.
Stock price evolution here is telling: During 2020’s equity build (BVPS to $18.80), shares bottomed at $8.25 amid panic but rebounded to $33 highs as fundamentals caught up. By 2024, with BVPS at $50, price highs of $53 implied a snug 1.06x PB—undervalued if growth persists.
Insider Activity: Confidence with a Side of Profit-Taking
Leadership insights emerge vividly from transactions. From April to October 2025, insiders scooped up shares aggressively: CEO of Merchants Capital (a key sub) bought 52,005 shares across deals (total cost ~$1.25 million at ~$30/share averages), joined by Pres/COO (4,000 shares), CFO (5,500 shares), and Chief Accounting Officer (3,353 shares). Total buys cost ~$1.63 million, signaling deep conviction at then-current levels amid rate uncertainty.
Contrast this with late-2025/early-2026 sells, dominated by Marhenke (COB/CEO/10% owner): ~100,000+ shares offloaded in November-December 2025 and February 2026 (total proceeds implied ~$1.85 million cost basis, but at prices yielding massive gains, given remaining holdings post-sale hovering ~$12-13 million). A Pres-Warehouse Lending chimed in with 5,500 shares sold. No buys since summer 2025, but zero sells earlier in the year. This pattern—sub-execs loading up early, top dog diversifying later—hints at aligned culture: operators betting on the business, founder harvesting after a decade’s run-up. Post-2023 crisis, such insider buying (vs. panic selling elsewhere) reinforced MBIN’s cultural edge in risk management.
Valuation Snapshot: Cheap, But Forward Risks Loom
Valuations scream value. Trailing PE dipped to 5.75x in 2024 (from 22x in 2016), PS to 1.13x, reflecting growth-at-reasonable-price. Compare to revenue/share explosion, and it’s a steal. Recent close trades at levels implying a forward 2025 PE around 10-13x on $3.53 EPS—still below historical averages and bank peers.
Analyst price targets cluster tightly: mean implies ~3% upside, high ~7%, low ~12% downside from recent levels. This modesty correlates with 2025’s projected reset—revenue down 54%, EPS halving—before rebounding (2026: $728 million revenue, +9%; 2027: $755 million, +4%; EPS to $5.79). If history rhymes, post-dip recovery could mirror 2020-21’s snapback.
Outlook: Cyclical Reset, Then Reacceleration?
Analysts foresee turbulence: 2025’s revenue cliff likely stems from mortgage warehouse runoff and CRE caution amid office vacancies and rate stickiness. But tailwinds beckon—falling rates could reignite multifamily demand, where MBIN owns ~20% market share. Employee growth plateauing post-2024 suggests cost discipline, potentially lifting margins back toward 40-50%. EPS trajectory (3.53 → 5.79 by 2027, +64%) implies 20%+ annualized returns if executed, aligning with ROE normalization at 20%.
Risks? Net debt at $3.9 billion exposes to deposit betas or CRE writedowns (though delinquency data absent here looks clean historically). Culture-wise, Marhenke’s sells don’t scream alarm—10% owners diversify routinely post-windfalls.
In sum, MBIN’s story is far from over: a decade of 30%+ growth forged a $2B+ equity fortress, insider bets affirm the moat, and valuations beckon contrarians. Bet on the cycle turning, and this could be your next regional bank multibagger—just mind the 2025 speed bump. (Word count: 1,128)